We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
-11.9%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.02B
AUM Growth
-$224M
Cap. Flow
-$66M
Cap. Flow %
-6.44%
Top 10 Hldgs %
37.29%
Holding
460
New
60
Increased
97
Reduced
133
Closed
90

Top Buys

Rank Stock Value
1
ERF
Enerplus Corporation
ERF
+$40.3M
2
EXE
Expand Energy Corp
EXE
+$31.8M
3
OVV icon
Ovintiv
OVV
+$27M
4
AAPL icon
Apple
AAPL
+$11.9M
5
CI icon
Cigna
CI
+$8.17M

Top Sells

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$34.5M
2
AR icon
Antero Resources
AR
+$25.9M
3
CTRA
Coterra Energy
CTRA
+$24M
4
DEN
Denbury Inc.
DEN
+$14.9M
5
HCA icon
HCA Healthcare
HCA
+$13.8M

Sector Composition

Rank Sector Weight
1 Energy 35.74%
2 Healthcare 12.12%
3 Technology 11.16%
4 Financials 9.37%
5 Consumer Discretionary 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SI
451
DELISTED
Silvergate Capital Corporation
SI
– –
-3,953
Closed -$595K
MIT
452
DELISTED
Mason Industrial Technology, Inc.
MIT
– –
-46,182
Closed -$451K
SHQAW
453
DELISTED
Shelter Acquisition Corporation I Warrants
SHQAW
– –
-56,600
Closed -$20K
GSQD.WS
454
DELISTED
G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
GSQD.WS
– –
-102,500
Closed -$41K
FRGE.WS
455
DELISTED
Forge Global Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock a
FRGE.WS
– –
-32,500
Closed -$54K
ENJY
456
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
– –
-36,857
Closed -$140K
TVTY
457
DELISTED
Tivity Health, Inc. Common Stock
TVTY
– –
-8,457
Closed -$272K
APSG.WS
458
DELISTED
Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer
APSG.WS
– –
-71,500
Closed -$98K
YELL
459
DELISTED
Yellow Corporation Common Stock
YELL
– –
-26,249
Closed -$184K
BHVN
460
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-7,215
Closed -$855K
15 16 17 18
19

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return

Advisory Research's Q2 2022 Portfolio in Review

As of Q2 2022, Advisory Research held 460 positions worth $1.02B, down 18% from $1.25B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Advisory Research withdrew a net $66M in Q2 2022, closing 90 positions and reducing 133 holdings. Its most notable exit was Coterra Energy, an estimated $24M position sold in full.

By sector, the portfolio is most concentrated in Energy at 36% of assets, up from 34% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Advisory Research opened a new position in Enerplus Corporation worth $38.7M.

  • Advisory Research's largest Q2 2022 buy was Enerplus Corporation: 2,926,378 shares worth $38.7M.
  • Advisory Research added most to Ovintiv in Q2 2022, an estimated $27M increase.
  • Advisory Research's biggest Q2 2022 reduction was Devon Energy, cutting an estimated $34.5M.
  • Advisory Research fully exited Coterra Energy in Q2 2022, selling an estimated $24M.
  • Advisory Research's ten largest holdings make up 37% of its $1.02B portfolio in Q2 2022.
  • Advisory Research opened 60 new positions and closed 90 in Q2 2022.
  • Advisory Research's portfolio value fell 18% quarter-over-quarter to $1.02B.

Based on Advisory Research's 13F filing for Q2 2022, filed 15 Aug 2022.